Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson’s Disease by Inhibiting the TLR/NF-κB Pathway
Bingyu Li, Pengli Xu, Shuyan Wu, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. 3, pp. 943-955
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
Yunna Li, Yun Xia, Sijia Yin, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 115
Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives
Prabhakar Semwal, Sakshi Painuli, Tareq Abu‐Izneid, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 110
Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases
Parama Dey, Monikongkona Boruah, Kumari Yachna, et al.
Life Sciences (2020) Vol. 260, pp. 118182-118182
Closed Access | Times Cited: 121
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 117
Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances
Bangrong Cai, Ying Zhang, Zengtao Wang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 89
Anti-inflammatory and modulatory effects of steroidal saponins and sapogenins on cytokines: A review of pre-clinical research
Fabíolla Rocha Santos Passos, Heitor G. Araújo-Filho, Brenda Souza Monteiro, et al.
Phytomedicine (2021) Vol. 96, pp. 153842-153842
Closed Access | Times Cited: 65
Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration
Mahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 1, pp. 4101-4123
Closed Access | Times Cited: 58
Anticancer Activity of Diosgenin and Its Molecular Mechanism
Qunli Ren, Qian Wang, Xin-Qun Zhang, et al.
Chinese Journal of Integrative Medicine (2023) Vol. 29, Iss. 8, pp. 738-749
Open Access | Times Cited: 23
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission
Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 86-97
Open Access | Times Cited: 13
Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation
Jinling Zhang, Xuemei Wang, Jifang Yang, et al.
European Journal of Medicinal Chemistry (2019) Vol. 186, pp. 111897-111897
Closed Access | Times Cited: 61
The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model
Shidi Wu, Mengjie Zhao, Yanhong Sun, et al.
Life Sciences (2019) Vol. 241, pp. 117115-117115
Closed Access | Times Cited: 56
Enriched Environment Attenuates Pyroptosis to Improve Functional Recovery After Cerebral Ischemia/Reperfusion Injury
Jingying Liu, Jun Zheng, Xu Yang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 35
Design and synthesis of diosgenin derivatives as apoptosis inducers through mitochondria-related pathways
Liwei Ma, Jinling Zhang, Xuemei Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113361-113361
Closed Access | Times Cited: 34
L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson’s disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters
Shivam Kumar, Anupam Awasthi, Khadga Raj, et al.
Psychopharmacology (2023) Vol. 240, Iss. 7, pp. 1493-1508
Open Access | Times Cited: 13
Neuroinflammation in CNS diseases: Molecular mechanisms and the therapeutic potential of plant derived bioactive molecules
Menizibeya O. Welcome
PharmaNutrition (2020) Vol. 11, pp. 100176-100176
Closed Access | Times Cited: 34
Inflammatory Animal Models of Parkinson’s Disease
Juan García‐Revilla, Antonio J. Herrera, Rocío M. de Pablos, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S165-S182
Open Access | Times Cited: 20
Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis
Rahul Patil, Rashmi S. Tupe
Medicinal Research Reviews (2023) Vol. 44, Iss. 1, pp. 365-405
Closed Access | Times Cited: 12
Exploring the therapeutic potential of Diosgenin as a Semaphorin-4D antagonist against neurodegenerative disorders
Ayushi Gupta, Princy Choudhary, Sneha Ranjan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110356-110356
Closed Access
Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance
Peirong Qu, Zhilin Jiang, Pingping Song, et al.
Pharmacological Research (2022) Vol. 182, pp. 106352-106352
Closed Access | Times Cited: 18
New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
Lorena Ortega Moreno, Ana Bagüés, Vicente Martı́nez, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2775-2775
Open Access | Times Cited: 9
Metformin attenuates LPS-induced neuronal injury and cognitive impairments by blocking NF-κB pathway
Chenliang Zhou, Bo Peng, Zhenghui Qin, et al.
BMC Neuroscience (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson’s disease rats via regulation of TLR/NF-κB signaling pathway
Xuelian Ma, Yutong Wang, Honglei Yin, et al.
Brain Research Bulletin (2021) Vol. 174, pp. 22-30
Closed Access | Times Cited: 22
Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1–42) induced neurotoxicity in animal model of Alzheimer’s disease
Swati Som, Antony Justin, S. P. Dhanabal, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 2, pp. 359-372
Open Access | Times Cited: 15
Alterations of Brain Quantitative Proteomics Profiling Revealed the Molecular Mechanisms of Diosgenin against Cerebral Ischemia Reperfusion Effects
Xinxin Zhang, Xingbin Wang, Muhammad Khurm, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 3, pp. 1154-1168
Closed Access | Times Cited: 22
Spermine protects aluminium chloride and iron-induced neurotoxicity in rat model of Alzheimer's disease via attenuation of tau phosphorylation, Amyloid-β (1–42) and NF-κB pathway
Khadga Raj, Ghanshyam Das Gupta, Shamsher Singh
Inflammopharmacology (2021) Vol. 29, Iss. 6, pp. 1777-1793
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top